Identification of Potential Serum Biomarkers for Rheumatoid Arthritis by High-Resolution Quantitative Proteomic Analysis

Inflammation

Volumn 37, Issue 5, 2014, Pages 1459-1467

  Cheng, Yongjing ^b   Chen, Yuling ^c   Sun, Xiaolin ^a   Li, Yuhui ^a   Huang, Cibo ^b   Deng, Haiteng ^c   Li, Zhanguo ^a  

^a PEKING UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c TSINGHUA UNIVERSITY   (China)

Author keywords

ficolin 2; orbitrap; proteomic analysis; rheumatoid arthritis

Indexed keywords

ALPHA 2 MACROGLOBULIN; ANGIOTENSINOGEN; APOLIPOPROTEIN A4; APOLIPOPROTEIN B100; APOLIPOPROTEIN C; APOLIPOPROTEIN C3; APOLIPOPROTEIN D; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; BIOLOGICAL MARKER; FIBRONECTIN; FICOLIN; FICOLIN 2; GLUTATHIONE PEROXIDASE 3; IMMUNOGLOBULIN M; PLASMINOGEN; PROTEOGLYCAN; PROTEOGLYCAN 4; RHEUMATOID FACTOR; SERUM AMYLOID A; SERUM AMYLOID P; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; PLASMA PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY SCORE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH STATUS INDICATOR; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETER; MIDDLE AGED; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS; SWOLLEN JOINT COUNT; TANDEM MASS SPECTROMETRY; ARTHRITIS, RHEUMATOID; BLOOD; DEVICES; MASS SPECTROMETRY; METABOLISM; PROCEDURES;

ADULT; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BLOOD PROTEINS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEOMICS;

EID: 84918818608     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9871-8     Document Type: Article

References (44)

1. Li, R., J. Sun, L.M. Ren, H.Y. Wang, W.H. Liu, X.W. Zhang, S. Chen, R. Mu, J. He, Y. Zhao, L. Long, Y.Y. Liu, X. Liu, X.L. Lu, Y.H. Li, S.Y. Wang, S.S. Pan, C. Li, and Z.G. Li. 2012. Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology (Oxford) 51: 721–729.
2. Panayi, G.S. 2005. B cells: a fundamental role in the pathogenesis of rheumatoid arthritis? Rheumatology (Oxford) 44(Suppl 2): ii3–ii7.
3. van Gaalen, F.A., S.P. Linn-Rasker, W.J. van Venrooij, B.A. de Jong, F.C. Breedveld, C.L. Verweij, R.E. Toes, and T.W. Huizinga. 2004. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis and Rheumatism 50: 709–715.
4. Canhao, H., A.M. Rodrigues, A.F. Mourao, F. Martins, M.J. Santos, J. Canas-Silva, J. Polido-Pereira, J.A. Pereira Silva, J.A. Costa, D. Araujo, C. Silva, H. Santos, C. Duarte, J.A. da Silva, F.M. Pimentel-Santos, J.C. Branco, E.W. Karlson, J.E. Fonseca, and D.H. Solomon. 2012. Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis. Rheumatology (Oxford) 51: 2020–2026.
5. Bykerk, V.P., S. Jamal, G. Boire, C.A. Hitchon, B. Haraoui, J.E. Pope, J.C. Thorne, Y. Sun, and E.C. Keystone. 2012. The Canadian Early Arthritis Cohort (CATCH): patients with new-onset synovitis meeting the 2010 ACR/EULAR classification criteria but not the 1987 ACR classification criteria present with less severe disease activity. Journal of Rheumatology 39: 2071–2080.
6. Jung, Y.O., and H.A. Kim. 2012. Recent paradigm shifts in the diagnosis and treatment of rheumatoid arthritis. Korean Journal of Internal Medicine 27: 378–387.
7. Apweiler, R., C. Aslanidis, T. Deufel, A. Gerstner, J. Hansen, D. Hochstrasser, R. Kellner, M. Kubicek, F. Lottspeich, E. Maser, H.W. Mewes, H.E. Meyer, S. Mullner, W. Mutter, M. Neumaier, P. Nollau, H.G. Nothwang, F. Ponten, A. Radbruch, K. Reinert, G. Rothe, H. Stockinger, A. Tarnok, M.J. Taussig, A. Thiel, J. Thiery, M. Ueffing, G. Valet, J. Vandekerckhove, W. Verhuven, C. Wagener, O. Wagner, and G. Schmitz. 2009. Approaching clinical proteomics: current state and future fields of application in fluid proteomics. Clinical Chemistry and Laboratory Medicine 47: 724–744.
8. Wang, J.G., W.D. Xu, W.T. Zhai, Y. Li, J.W. Hu, B. Hu, M. Li, L. Zhang, W. Guo, J.P. Zhang, L.H. Wang, and B.H. Jiao. 2012. Disorders in angiogenesis and redox pathways are main factors contributing to the progression of rheumatoid arthritis: a comparative proteomics study. Arthritis and Rheumatism 64: 993–1004.
9. Liao, H., J. Wu, E. Kuhn, W. Chin, B. Chang, M.D. Jones, S. O’Neil, K.R. Clauser, J. Karl, F. Hasler, R. Roubenoff, W. Zolg, and B.C. Guild. 2004. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis and Rheumatism 50: 3792–3803.
10. Jin, E.H., S.C. Shim, H.G. Kim, S.C. Chae, and H.T. Chung. 2009. Polymorphisms of COTL1 gene identified by proteomic approach and their association with autoimmune disorders. Experimental and Molecular Medicine 41: 354–361.
11. Makarov, A., E. Denisov, O. Lange, and S. Horning. 2006. Dynamic range of mass accuracy in LTQ Orbitrap hybrid mass spectrometer. Journal of The American Society for Mass Spectrometry 17: 977–982.
12. Makarov, A., E. Denisov, A. Kholomeev, W. Balschun, O. Lange, K. Strupat, and S. Horning. 2006. Performance evaluation of a hybrid linear ion trap/orbitrap mass spectrometer. Analytical Chemistry 78: 2113–2120.
13. Raso, C., C. Cosentino, M. Gaspari, N. Malara, X. Han, D. McClatchy, S.K. Park, M. Renne, N. Vadala, U. Prati, G. Cuda, V. Mollace, F. Amato, and J.R. Yates 3rd. 2012. Characterization of breast cancer interstitial fluids by TmT labeling, LTQ-Orbitrap Velos mass spectrometry, and pathway analysis. Journal of Proteome Research 11: 3199–3210.
14. Aletaha, D., T. Neogi, A.J. Silman, J. Funovits, D.T. Felson, C.O. Bingham 3rd, N.S. Birnbaum, G.R. Burmester, V.P. Bykerk, M.D. Cohen, B. Combe, K.H. Costenbader, M. Dougados, P. Emery, G. Ferraccioli, J.M. Hazes, K. Hobbs, T.W. Huizinga, A. Kavanaugh, J. Kay, T.K. Kvien, T. Laing, P. Mease, H.A. Menard, L.W. Moreland, R.L. Naden, T. Pincus, J.S. Smolen, E. Stanislawska-Biernat, D. Symmons, P.P. Tak, K.S. Upchurch, J. Vencovsky, F. Wolfe, and G. Hawker. 2010. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Annals of the Rheumatic Diseases 69: 1580–1588.
15. (1980). Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23:581-590.
16. International Study Group for Behcet’s Disease. 1990. Criteria for diagnosis of Behcet’s disease. Lancet 335: 1078–1080.
17. Altman, R.D. 1995. The classification of osteoarthritis. Journal of Rheumatology. Supplement 43: 42–43.
18. Hu, S., J.A. Loo, and D.T. Wong. 2007. Human saliva proteome analysis. Annals of the New York Academy of Sciences 1098: 323–329.
19. Hu, S., J.A. Loo, and D.T. Wong. 2006. Human body fluid proteome analysis. Proteomics 6: 6326–6353.
20. Serada, S., M. Fujimoto, A. Ogata, F. Terabe, T. Hirano, H. Iijima, S. Shinzaki, T. Nishikawa, T. Ohkawara, K. Iwahori, N. Ohguro, T. Kishimoto, and T. Naka. 2010. iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases. Annals of the Rheumatic Diseases 69: 770–774.
21. Zheng, X., S.L. Wu, M. Hincapie, and W.S. Hancock. 2009. Study of the human plasma proteome of rheumatoid arthritis. Journal of Chromatography A 1216: 3538–3545.
22. Falgarone, G., A. Essabbani, F. Dumont, N. Cagnard, S. Mistou, and G. Chiocchia. 2011. Implication of clusterin in TNF-alpha response of rheumatoid synovitis: lesson from in vitro knock-down of clusterin in human synovial fibroblast cells. Physiological Genomics 44: 229–235.
23. Przybysz, M., K. Borysewicz, and I. Katnik-Prastowska. 2013. Fibronectin molecular status determination useful to differentiate between rheumatoid arthritis and systemic lupus erythematosus patients. Rheumatology International 33: 37–43.
24. Biro, J., Z. Balogh, M. Szongoth, A. Megyeri, M. Bely, and A. Falus. 1992. Molecular genetic, laboratory and clinical study of serum amyloid P. Orvosi Hetilap 133: 841–845.
25. Friese, M.A., T. Manuelian, S. Junnikkala, J. Hellwage, S. Meri, H.H. Peter, D.L. Gordon, H. Eibel, and P.F. Zipfel. 2003. Release of endogenous anti-inflammatory complement regulators FHL-1 and factor H protects synovial fibroblasts during rheumatoid arthritis. Clinical and Experimental Immunology 132: 485–495.
26. Jacobson, G.A., S.J. Ives, C. Narkowicz, and G. Jones. 2012. Plasma glutathione peroxidase (GSH-Px) concentration is elevated in rheumatoid arthritis: a case-control study. Clinical Rheumatology 31: 1543–1547.
27. van Beers, J.J., C.M. Schwarte, J. Stammen-Vogelzangs, E. Oosterink, B. Bozic, and G.J. Pruijn. 2013. The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and beta-actin. Arthritis and Rheumatism 65: 69–80.
28. Ichijo, H., L. Ronnstrand, K. Miyagawa, H. Ohashi, C.H. Heldin, and K. Miyazono. 1991. Purification of transforming growth factor-beta 1 binding proteins from porcine uterus membranes. Journal of Biological Chemistry 266: 22459–22464.
29. Endo, Y., M. Matsushita, and T. Fujita. 2011. The role of ficolins in the lectin pathway of innate immunity. International Journal of Biochemistry and Cell Biology 43: 705–712.
30. Endo, Y., N. Nakazawa, D. Iwaki, M. Takahashi, M. Matsushita, and T. Fujita. 2010. Interactions of ficolin and mannose-binding lectin with fibrinogen/fibrin augment the lectin complement pathway. Journal of Innate Immunity 2: 33–42.
31. Matsushita, M. 2010. Ficolins: complement-activating lectins involved in innate immunity. Journal of Innate Immunity 2: 24–32.
32. Krarup, A., U.B. Sorensen, M. Matsushita, J.C. Jensenius, and S. Thiel. 2005. Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infection and Immunity 73: 1052–1060.
33. Aoyagi, Y., E.E. Adderson, C.E. Rubens, J.F. Bohnsack, J.G. Min, M. Matsushita, T. Fujita, Y. Okuwaki, and S. Takahashi. 2008. L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway. Infection and Immunity 76: 179–188.
34. Kuraya, M., Z. Ming, X. Liu, M. Matsushita, and T. Fujita. 2005. Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation. Immunobiology 209: 689–697.
35. Zhang, J., J. Koh, J. Lu, S. Thiel, B.S. Leong, S. Sethi, C.Y. He, B. Ho, and J.L. Ding. 2009. Local inflammation induces complement crosstalk which amplifies the antimicrobial response. PLoS Pathogens 5: e1000282.
36. Nakaya, H.I., J. Gardner, Y.S. Poo, L. Major, B. Pulendran, and A. Suhrbier. 2012. Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis. Arthritis and Rheumatism 64: 3553–3563.
37. Pender, M.P. 2012. CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis. Autoimmune Diseases 2012: 189096.
38. Ammitzboll, C.G., S. Thiel, T. Ellingsen, B. Deleuran, A. Jorgensen, J.C. Jensenius, and K. Stengaard-Pedersen. 2012. Levels of lectin pathway proteins in plasma and synovial fluid of rheumatoid arthritis and osteoarthritis. Rheumatology International 32: 1457–1463.
39. Vander Cruyssen, B., L. Nuytinck, L. Boullart, D. Elewaut, W. Waegeman, M. Van Thielen, E. De Meester, K. Lebeer, R. Rossau, and F. De Keyser. 2007. Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis. Rheumatology (Oxford) 46: 1792–1795.
40. Kolarov, Z., R. Stoilov, M. Baleva, K. Nikolov, I. Sheitanov, M. Iancheva, N. Tsacheva, and S. Radenska-Lopovok. 2000. Alpha-2 macroglobulin in serum and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis. Terapevticheskiĭ Arkhiv 72: 17–19.
41. Isik, A., S.S. Koca, B. Ustundag, H. Celik, and A. Yildirim. 2007. Paraoxonase and arylesterase levels in rheumatoid arthritis. Clinical Rheumatology 26: 342–348.
42. Li, J., Y. Guo, R. Holmdahl, and T. Ny. 2005. Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. Arthritis and Rheumatism 52: 2541–2548.
43. Busso, N., V. Peclat, K. Van Ness, E. Kolodziesczyk, J. Degen, T. Bugge, and A. So. 1998. Exacerbation of antigen-induced arthritis in urokinase-deficient mice. Journal of Clinical Investigation 102: 41–50.
44. Metsarinne, K.P., D.C. Nordstrom, Y.T. Konttinen, A.M. Teppo, and F.Y. Fyhrquist. 1992. Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis, and systemic lupus erythematosus. Rheumatology International 12: 93–96.